The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
Open accessAbstract
Covid-19 Antibodies after Mild Infection Among 34 volunteers who had recovered from mild Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein declined wi...
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, neutralizing antibody responses decay rapidly in early convalescence9,14–17.”
From Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection (2021) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Stadlbauer, D., Amanat, F., Chromikova, V., Jiang, K., Strohmeier, S., Arunkumar, G. A., Tan, J., Bhavsar, D., Capuano, C., Roubidoux, E. K., et al. (2020) · Current Protocols in Microbiology · doi:10.1002/cpmc.100 · Cited by 635
Disappearance of Antibodies to SARS-Associated Coronavirus after Recovery
Cao, W.-C., Liu, W., Zhang, P.-H., Zhang, F., & Richardus, J. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070348 · Cited by 367
Andraud, M., Lejeune, O., Musoro, J. Z., Ogunjimi, B., Beutels, P., & Hens, N. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002418 · Cited by 75
Chang, S., Wang, J., Huang, L., Chen, Y., Fang, C., Sheng, W., Wang, J., Yu, C., & Yang, P. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.12.1455-1457.2005 · Cited by 32
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,002
An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages
Motamedi, H., Ari, M. M., Dashtbin, S., Fathollahi, M., Hossainpour, H., Alvandi, A., Moradi, J., & Abiri, R. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107763 · Cited by 51
Johnston, M., Ates, H. C., Glatz, R. T., Mohsenin, H., Schmachtenberg, R., Göppert, N., Huzly, D., Urban, G. A., Weber, W., & Dincer, C. (2022) · Materials Today · doi:10.1016/j.mattod.2022.11.001 · Cited by 50
Understanding protection from SARS-CoV-2 by studying reinfection
Overbaugh, J. M. (2020) · Nature Medicine · doi:10.1038/s41591-020-1121-z · Cited by 48
Schaffner, A., Risch, L., Aeschbacher, S., Risch, C., Weber, M. C., Thiel, S. L., Jüngert, K., Pichler, M., Grossmann, K., Wohlwend, N., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123989 · Cited by 44
Complement Factors in COVID-19 Therapeutics and Vaccines
Kurtovic, L., & Beeson, J. G. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.12.002 · Cited by 47
Goh, Y. S., Chavatte, J., Jieling, A. L., Lee, B. T. K., Hor, P. X., Amrun, S. N., Lee, C. Y., Chee, R. S., Wang, B., Lee, C. Y., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100193 · Cited by 48
Brüssow, H. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.15302 · Cited by 54
Follmann, D. A., Fintzi, J., Fay, M. P., Janes, H., Baden, L. R., Sahly, H. M. E., Fleming, T. R., Mehrotra, D. V., Carpp, L. N., Juraska, M., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m20-8149 · Cited by 48
Germanio, C. D., Simmons, G., Kelly, K. K., Martinelli, R., Darst, O., Azimpouran, M., Stone, M., Hazegh, K. E., Grebe, E., Zhang, S., et al. (2021) · Transfusion · doi:10.1111/trf.16555 · Cited by 44
Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19
Ripoll, J. G., van Helmond, N., Senefeld, J. W., Wiggins, C. C., Klassen, S. A., Baker, S. E., Larson, K. F., Murphy, B. M., Andersen, K. J., Ford, S. K., et al. (2021) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2021.02.001 · Cited by 46
Using excess deaths and testing statistics to determine COVID-19 mortalities
Böttcher, L., D'Orsogna, M. R., & Chou, T. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00748-2 · Cited by 48
How long does covid-19 immunity last?
Baraniuk, C. (2021) · BMJ · doi:10.1136/bmj.n1605 · Cited by 45
SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients
Makatsa, M. S., Tincho, M. B., Wendoh, J. M., Ismail, S. D., Nesamari, R., Pêra, F. F. P. G., Beer, S., David, A., Jugwanth, S., Gededzha, M. P., et al. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.589940 · Cited by 49
Li, Y., Xu, Z., Lei, Q., Lai, D., Hou, H., Jiang, H., Zheng, Y.-X., Wang, X., Wu, J., Ma, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109391 · Cited by 43
SARS-CoV-2 antibody prevalence in health care workers: Preliminary report of a single center study
Brant-Zawadzki, M. N., Fridman, D., Robinson, P. A., Zahn, M., Chau, C., German, R., Breit, M., Bock, J. R., & Hara, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240006 · Cited by 43
Dorigatti, I., Lavezzo, E., Manuto, L., Ciavarella, C., Pacenti, M., Boldrin, C., Cattai, M., Saluzzo, F., Franchin, E., Vecchio, C. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24622-7 · Cited by 44
Chen, J., Liu, X., Zhang, X., Lin, Y., Liu, D., Xun, J., Wang, Z., Gu, L., Li, Q., Yin, D., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1319 · Cited by 44
SARS-CoV-2 reinfection in patients negative for immunoglobulin G following recovery from COVID-19
Ali, A. M., Ali, K., Fatah, M. H., Tawfeeq, H. M., & Rostam, H. M. (2021) · New Microbes and New Infections · doi:10.1016/j.nmni.2021.100926 · Cited by 46
Havervall, S., Falk, A. J., Klingström, J., Ng, H., Greilert‐Norin, N., Gabrielsson, L., Salomonsson, A., Isaksson, E., Rudberg, A., Hellström, C., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262169 · Cited by 45
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants
Chen, M., Pekosz, A. S., Villano, J., Shen, W., Zhou, R., Kulaga, H. M., Li, Z., Smith, A. K., Gurung, A., Beck, S. E., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174439 · Cited by 52
Burack, D., Pereira, M. R., Tsapepas, D. S., Harren, P. A., FARR, M. A., Arcasoy, S. M., Cohen, D. J., Mohan, S., Emond, J. C., Hod, E. A., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16541 · Cited by 45
Peng, R., Pan, Y., Li, Z., Qin, Z., Rini, J. M., & Liu, X. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113762 · Cited by 45
COVID ‐19 and plasma cells: Is there long‐lived protection?*
Nguyen, D. C., Lamothe, P. A., Woodruff, M. C., Saini, A. S., Faliti, C. E., Sanz, I., & Lee, F. E.-H. (2022) · Immunological Reviews · doi:10.1111/imr.13115 · Cited by 48
T cell perturbations persist for at least 6 months following hospitalization for COVID-19
Govender, M., Hopkins, F. R., Göransson, R., Svanberg, C., Shankar, E. M., Hjorth, M., Nilsdotter‐Augustinsson, Å., Sjöwall, J., Nyström, S. N., & Larsson, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931039 · Cited by 43
Use of machine learning to identify a T cell response to SARS-CoV-2
Shoukat, M. S., Foers, A. D., Woodmansey, S., Evans, S. C., Fowler, A., & Soilleux, E. J. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100192 · Cited by 42
Moore, J. L., Ganapathiraju, P. V., Kurtz, C. P., & Wainscoat, B. (2020) · American Journal of Case Reports · doi:10.12659/ajcr.927812 · Cited by 39
Mehdi, F., Chattopadhyay, S., Thiruvengadam, R., Sarla, Y., Kumar, M., Sinha, S. K., Goswami, S., Kshetrapal, P., Wadhwa, N., Natchu, U. C. M., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.618097 · Cited by 40
Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium
Rello, J., Belliato, M., Dimopoulos, M. A., Giamarellos‐Bourboulis, E. J., Jaksic, V., Martín‐Loeches, I., Mporas, I., Pelosi, P. P., Poulakou, G., Pournaras, S., et al. (2020) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2020.10.008 · Cited by 41
Mulchandani, R., Jones, H. E., Taylor‐Phillips, S., Shute, J., Perry, K. R., Jamarani, S., Brooks, T. J. G., Charlett, A., Hickman, M., Oliver, I., et al. (2020) · BMJ · doi:10.1136/bmj.m4262 · Cited by 38
Terpos, E., Politou, M., Sergentanis, T. Ν., Mentis, A. F., Rosati, M., Stellas, D., Bear, J., Hu, X., Felber, B. K., Pappa, V., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8121885 · Cited by 46
Gao, L., Zhou, J., Yang, S., Wang, L., Chen, X., Yang, Y., Li, R., Pan, Z., Zhao, Y., Li, Z., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00525-3 · Cited by 39
Amellal, H., Assaid, N., Charoute, H., Akarid, K., Maaroufi, A., Ezzikouri, S., & Sarih, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288557 · Cited by 40
Kumar, V. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106980 · Cited by 42
Sá, M., Mirza, L., Carter, M. J., Jones, L. C., Gowda, V. L., Handforth, J., Hedderly, T. J., Kenny, J. M., Lascelles, K., Lin, J., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000999 · Cited by 41
Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2
McConnell, D. J., Hickey, C., Bargary, N., Trela-Larsen, L., Walsh, C., Barry, M. G., & Adams, R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094640 · Cited by 43
Janus Emulsion Biosensors for Anti-SARS-CoV-2 Spike Antibody
Li, J., Concellón, A., Yoshinaga, K., Nelson, Z. P., He, Q., & Swager, T. M. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00173 · Cited by 41
Candon, S., Guerrot, D., Drouot, L., Lemoine, M., Lebourg, L., Hanoy, M., Boyer, O., & Bertrand, D. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16348 · Cited by 41
What the Omicron wave is revealing about human immunity
Willyard, C. (2022) · Nature · doi:10.1038/d41586-022-00214-3 · Cited by 38
Emmenegger, M., Cecco, E. D., Lamparter, D., Jacquat, R. P. B., Riou, J., Menges, D., Ballouz, T., Ebner, D. V., Schneider, M. M., Morales, I. C., et al. (2023) · iScience · doi:10.1101/2020.05.31.20118554 · Cited by 34
Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
Lu, L., Zhang, H., Zhan, M., Jiang, J., Yin, H., Dauphars, D. J., Li, S.-Y., Li, Y., & He, Y.-W. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1859-y · Cited by 41
Immune memory in convalescent patients with asymptomatic or mild COVID-19
Long, Q., Jia, Y., Wang, X., Deng, H., Cao, X., Yuan, J., Fang, L., Cheng, X.-R., Luo, C., He, A.-R., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00250-9 · Cited by 41
Review on oxidative stress relation on COVID-19: Biomolecular and bioanalytical approach
Ebrahimi, M., Norouzi, P., Aazami, H., & Moosavi‐Movahedi, A. A. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.08.095 · Cited by 43
Manthei, D. M., Whalen, J., Schroeder, L. F., Sinay, A. M., Li, S., Valdez, R., Giacherio, D. A., & Gherasim, C. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa200 · Cited by 39
Over 1‐year duration and age difference of SARS‐CoV‐2 antibodies in convalescent COVID‐19 patients
Zeng, F., Wu, M., Wang, J., Li, J., Hu, G., & Wang, L. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27152 · Cited by 40
Giroux, N. S., Ding, S., McClain, M. T., Burke, T. W., Petzold, E., Chung, H. A., Rivera, G. O., Wang, E., Xi, R., Bose, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15668-8 · Cited by 40
Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients
Wang, Y., Li, J., Li, H., Lei, P., Shen, G., & Yang, C. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107271 · Cited by 40
Dopico, X. C., Muschiol, S., Christian, M., Hanke, L., Sheward, D. J., Grinberg, N. F., Rorbach, J., Bogdanović, G., McInerney, G. M., Allander, T., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13304 · Cited by 36
Herrington, D. M., Sanders, J. W., Wierzba, T. F., Alexander‐Miller, M. A., Espeland, M. A., Bertoni, A. G., Mathews, A., Seals, A. L., Munawar, I., Runyon, M. S., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06517-6 · Cited by 36
COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments
Laroni, A., Schiavetti, I., Sormani, M. P., & Uccelli, A. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520971817 · Cited by 40
Decline of antibody titres 3 months after two doses of BNT162b2 in non-immunocompromised adults
Erice, A., Varillas‐Delgado, D., & Caballero, C. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.08.023 · Cited by 39
COVID-19 Immunobiology: Lessons Learned, New Questions Arise
Kaklamanos, A., Belogiannis, K., Skendros, P., Gorgoulis, V. G., Vlachoyiannopoulos, P. G., & Tzioufas, A. G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719023 · Cited by 37
Optimal lockdown in altruistic economies
Stefano Bosi, Y., Camacho, C., & Desmarchelier, D. (2021) · Journal of Mathematical Economics · doi:10.1016/j.jmateco.2021.102488 · Cited by 38
Okarska‐Napierała, M., Ludwikowska, K. M., Szenborn, L., Dudek, N., Mania, A., Buda, P., Książyk, J., Mazur‐Melewska, K., Figlerowicz, M., Szczukocki, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113386 · Cited by 36
Martínez‐Fleta, P., Alfranca, A., González‐Álvaro, I., Casasnovas, J. M., Fernández‐Soto, D., Esteso, G., Cáceres‐Martell, Y., Gardeta, S. R., López‐Sanz, C., Prat, S., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000842 · Cited by 38
Robust estimation of diagnostic rate and real incidence of COVID-19 for European policymakers
Català, M., Pino, D., Marchena, M., Palacios, P. A., Urdiales, T., Cardona, P.-J., Alonso, S., López, D., Prats, C., & Álvarez-Lacalle, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0243701 · Cited by 40
Strömer, A., Rose, R., Grobe, O., Neumann, F., Fickenscher, H., Lorentz, T., & Krumbholz, A. (2020) · Microorganisms · doi:10.3390/microorganisms8101572 · Cited by 35
Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms
Cappel, M. A., Cappel, J. A., & Wetter, D. A. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.01.009 · Cited by 36
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays
Fotis, C., Meimetis, N., Tsolakos, N., Politou, M., Akinosoglou, K., Pliaka, V., Minia, A., Terpos, E., Trougakos, I. P., Mentis, A. F., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86035-2 · Cited by 35
Spicer, K. B., Glick, C., Cavanaugh, A. M., & Thoroughman, D. A. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.10.010 · Cited by 36
Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection
Dehgani‐Mobaraki, P., Zaidi, A. K., Yadav, N., Floridi, A., & Floridi, E. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108814 · Cited by 34
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
Shafqat, A., Shafqat, S., Alsalameh, S., Kashir, J., AlKattan, K. M., & Yaqinuddin, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835104 · Cited by 37
Jia, X., Cao, S., Lee, A., Manohar, M., Sindher, S., Ahuja, N. K., Artandi, M. K., Blish, C. A., Blomkalns, A. L., Chang, I., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.156713 · Cited by 35
Anti-SARS-CoV-2 Antibodies Persist for up to 13 Months and Reduce Risk of Reinfection
Gallais, F., Gantner, P., Bruel, T., Velay, A., Planas, D., Wendling, M.-J., Bayer, S., Solis, M., Laugel, E., Reix, N., et al. (2021) · doi:10.1101/2021.05.07.21256823 · Cited by 240
Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
Vignesh, R., Shankar, E. M., Velu, V., & Thyagarajan, S. P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586781 · Cited by 37
Högelin, K. A., Ruffin, N., Pin, E., Månberg, A., Hober, S., Gafvelin, G., Grönlund, H., Nilsson, P., Khademi, M., Olsson, T. P., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103078 · Cited by 34
Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review
Pérez, J., Ramírez, C. A. P., Cañadas, C., Aguirre, D., Pibaque, R., Bedón-Galarza, R., Sempértegui, F., Drexhage, H. A., & Baldeón, L. (2021) · Vaccines · doi:10.3390/vaccines9020102 · Cited by 34
Horndler, L., Delgado, P., Abia, D., Balabanov, I., Martínez‐Fleta, P., Cornish, G. H., Llamas, M. Á., Villar, S. S., Sánchez‐Madrid, F., Fresno, M., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013549 · Cited by 35
Schoenhals, M. J., Rabenindrina, N., Rakotondramanga, J. M., Dussart, P., Randremanana, R. V., Héraud, J., Andriamandimby, S. F., Sahondranirina, P. H., Vololoniaina, M. C., Randriatsarafara, F. M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103419 · Cited by 34
Mishra, S. K., Pradhan, S. K., Pati, S., Sahu, S., & Nanda, R. K. (2021) · Cureus · doi:10.7759/cureus.19879 · Cited by 37
How Iceland hammered COVID with science
Scudellari, M. (2020) · Nature · doi:10.1038/d41586-020-03284-3 · Cited by 34
Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
Taefehshokr, N., Taefehshokr, S., & Heit, B. (2020) · Pathogens · doi:10.3390/pathogens9121027 · Cited by 35
A modified coronavirus herd immunity optimizer for capacitated vehicle routing problem
Dalbah, L. M., Al‐Betar, M. A., Awadallah, M. A., & Zitar, R. A. (2021) · Journal of King Saud University - Computer and Information Sciences · doi:10.1016/j.jksuci.2021.06.013 · Cited by 36
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel
Glück, V., Grobecker, S., Köstler, J., Tydykov, L., Bertok, M., Weidlich, T., Gottwald, C., Salzberger, B., Wagner, R., Zeman, F., et al. (2021) · Infection · doi:10.1007/s15010-021-01703-9 · Cited by 35
SARS‐CoV‐2 during pregnancy and associated outcomes: Results from an ongoing prospective cohort
Molenaar, N. M., Rommel, A., de Witte, L. D., Dolan, S. M., Lieb, W., Ibroçi, E., Ohrn, S., Lynch, J., Capuano, C., Stadlbauer, D., et al. (2021) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12812 · Cited by 36
Khairullin, B. M., Zakarya, K. D., Orynbayev, M. B., Abduraimov, Y. O., Kassenov, M., Sarsenbayeva, G., Sultankulova, K. T., Chervyakova, O. V., Myrzakhmetova, B. S., Куралбаевич, Н. А., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101526 · Cited by 36
Diamanti, A. P., Cattaruzza, M. S., Rosa, R. D., Porto, F. D., Salemi, S., Sorgi, M. L., Martin, L. S. M., Rai, A., Iacono, D., Sesti, G., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8111818 · Cited by 32
Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2
Amjadi, M. F., O’Connell, S. E., Armbrust, T., Mergaert, A. M., Narpala, S., Halfmann, P., Bashar, S. J., Glover, C. R., Heffron, A. S., Taylor, A., et al. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100022 · Cited by 34
Fernández‐González, M., Agulló, V., Padilla, S., García, J. A., García‐Abellán, J., Botella, Á., Mascarell, P., Ruiz‐García, M., Masiá, M., & Gutiérrez, F. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab1021 · Cited by 34
Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies
Yousefi, Z., Taheri, N., Dargahi, M., Chaman, R., Binesh, E., Emamian, M. H., & Jafari, R. (2022) · Current Microbiology · doi:10.1007/s00284-022-02800-0 · Cited by 31
Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID
Krishna, B. A., Lim, E. Y., Mactavous, L., Lyons, P., Döffinger, R., Bradley, J. R., Smith, K. G. C., Sinclair, J. H., Matheson, N. J., Lehner, P. J., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104129 · Cited by 32
Menges, D., Zens, K. D., Ballouz, T., Caduff, N., Llanas-Cornejo, D., Aschmann, H. E., Domenghino, A., Pellaton, C., Perreau, M., Fenwick, C. W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32573-w · Cited by 32
Blain, H., Tuaillon, É., Gamon, L., Pisoni, A., Miot, S., Rolland, Y., Picot, M., & Bousquet, J. J. (2021) · Allergy · doi:10.1111/all.15007 · Cited by 31
Rosati, M., Terpos, E., Ntanasis‐Stathopoulos, I., Agarwal, M., Bear, J., Burns, R. T., Hu, X., Korompoki, E., Donohue, D. E., Venzon, D. J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.793953 · Cited by 34
Tirelli, C., AMICI, M. D., Albrici, C., Mira, S., Nalesso, G., Re, B., Corsico, A. G., Mondoni, M., & Centanni, S. (2023) · Biology · doi:10.3390/biology12020177 · Cited by 35
Orologas‐Stavrou, N., Politou, M., Rousakis, P., Kostopoulos, I. V., Ntanasis‐Stathopoulos, I., Jahaj, E., Tsiligkeridou, E., Gavriatopoulou, M., Kastritis, E., Kotanidou, Α., et al. (2020) · Viruses · doi:10.3390/v13010026 · Cited by 34
Liu, B., Su, X., Yu, G., Yang, S.-L., Wang, F., Huang, T., Zhou, L., Hui, Z., Liao, Y., Qiu, Y., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.12.316 · Cited by 32
Zhang, B., Tian, J., Zhang, Q., Xie, Y., Wang, K., Qiu, S., Lu, K., & Liu, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.761173 · Cited by 36
Wu, M., Wu, S., Wang, G., Liu, W., Chu, L. T., Jiang, T., Kwong, H. K., Chow, H. L., Li, I. W. S., & Chen, T. (2022) · Science Advances · doi:10.1126/sciadv.abn6064 · Cited by 35
Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study
Arroyo, R. A., Portolés, J. M., Sánchez, P. L., Zalamea, F., Furaz, K., Méndez, Á., Nieto, L., Sánchez-Hernández, R., Pizarro, S. O., García, A., et al. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab048 · Cited by 31
Mattiuzzi, C., Henry, B. M., Sanchis‐Gomar, F., & Lippi, G. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i3.10303 · Cited by 31
Sasisekharan, V., Pentakota, N., Jayaraman, A., Tharakaraman, K., Wogan, G. N., & Narayanasami, U. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021615118 · Cited by 30
COVID-19 reinfection in the presence of neutralizing antibodies
Zhang, J., Ding, N., Ren, L., Song, R., Chen, D., Zhao, X., Chen, B., Han, J., Li, J., Song, Y., et al. (2021) · National Science Review · doi:10.1093/nsr/nwab006 · Cited by 30
Kagucia, E. W., Gitonga, J. N., Kalu, C., Ochomo, E., Ochieng, B. O., Kuya, N. A., Karani, A., Nyagwange, J., Karia, B., Mugo, D., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab314 · Cited by 28
Wagner, A., Guzek, A., Ruff, J., Jasińska, J., Scheikl, U., Zwazl, I., Kundi, M., Stockinger, H. S. J., Farcet, M. R., Kreil, T. R., et al. (2021) · Communications Medicine · doi:10.1038/s43856-021-00012-4 · Cited by 28
Lagerqvist, N., Maleki, K. T., Verner‐Carlsson, J., Olausson, M., Dillner, J., Byström, J. W., Monsen, T., Forsell, M. N. E., Eriksson, J., Bogdanović, G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87289-6 · Cited by 31
Gontu, A., Srinivasan, S., Salazar, E., Nair, M. S., Nissly, R. H., Greenawalt, D. I., Bird, I. M., Herzog, C. M., Ferrari, M. J., Poojary, I. B., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01813-y · Cited by 28
Kataria, Y., Cole, M., Duffy, E. R., Cena, K. O. C. D. L., Schechter‐Perkins, E. M., Bouton, T. C., Werler, M. M., Pierre, C. M., Ragan, E. J., Weber, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-89107-5 · Cited by 30
Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2
Trombetta, B. A., Kandigian, S. E., Kitchen, R. R., Grauwet, K., Webb, P. K., Miller, G. A., Jennings, C. G. B., Jain, S. V., Miller, S. M., Kuo, Y., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06257-7 · Cited by 30
Molnár, T., Várnai, R., Schranz, D., Závori, L., Péterfi, Z., Sipos, D., Tökés‐Füzesi, M., Illés, Z., Büki, A., & Csécsei, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194337 · Cited by 31
Vigón, L., García‐Pérez, J., Rodríguez-Mora, S., Torres, M., Mateos, E., de la Osa, M. C., Cervero, M., de Molina, R. M., Navarro, C., Murciano-Antón, M. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742631 · Cited by 31
Metadata
- Authors
- Ibarrondo, F. J., Fulcher, J. A., Goodman-Meza, D., Elliott, J., Hofmann, C., Hausner, M. A., Ferbas, K. G., Tobin, N. H., Aldrovandi, G. M., & Yang, O. O.
- Affiliations
- University of California, Los Angeles (US)
- David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA
- Corresponding author
- Yang, Otto O.
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-09-10
- Volume
- 383
- Issue
- 11
- Pages
- 1085-1087
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC7397184
- OpenAlex
- W3044311014
- Cited by
- 1,021
- References
- 5
- Citations by year
- 2026: 12 · 2025: 28 · 2024: 36 · 2023: 92 · 2022: 198 · 2021: 476 · 2020: 177
- FWCI
- 30.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- McCarthy Family Foundation
- AIDS Healthcare Foundation (Grant to OOY)
- National Institutes of National Institute of Allergy and Infectious Diseases (AI124979, AI131879, AI140775, UM1AI068616, UM1AI068632, UM1AI106716)
- Doris Duke Charitable Foundation (2019086)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute of Mental Health
- James B. Pendleton Charitable Trust
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, antibody persistence, anti-spike antibodies, receptor binding domain, mild COVID-19, antibody waning
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Adult, Aged, Antibodies, Viral, Female, Humans, Immunoglobulin G, Male, Middle Aged, Pneumonia, Viral, Coronavirus Infections, Young Adult, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
